G. Caleb Alexander

23.7k total citations · 8 hit papers
355 papers, 16.8k citations indexed

About

G. Caleb Alexander is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Geriatrics and Gerontology. According to data from OpenAlex, G. Caleb Alexander has authored 355 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Public Health, Environmental and Occupational Health, 100 papers in Economics and Econometrics and 59 papers in Geriatrics and Gerontology. Recurrent topics in G. Caleb Alexander's work include Opioid Use Disorder Treatment (75 papers), Pharmaceutical Practices and Patient Outcomes (58 papers) and Health Systems, Economic Evaluations, Quality of Life (57 papers). G. Caleb Alexander is often cited by papers focused on Opioid Use Disorder Treatment (75 papers), Pharmaceutical Practices and Patient Outcomes (58 papers) and Health Systems, Economic Evaluations, Quality of Life (57 papers). G. Caleb Alexander collaborates with scholars based in United States, United Kingdom and Canada. G. Caleb Alexander's co-authors include Dima M. Qato, Randall S. Stafford, Hsien‐Yen Chang, Stacy Tessler Lindau, L. Philip Schumm, Matthew Daubresse, Catherine S. Hwang, Rena M. Conti, Mark C. Bicket and Eleanor Lucas and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

G. Caleb Alexander

348 papers receiving 16.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

2015 1.0k citations G. Caleb Alexander et al. profile →
Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States

2008 737 citations Dima M. Qato, G. Caleb Alexander et al. profile →
Prescription Opioid Analgesics Commonly Unused After Surgery

2017 663 citations G. Caleb Alexander et al. profile →
National Trends in Ambulatory Oral Anticoagulant Use

2015 454 citations G. Caleb Alexander et al. profile →
Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011

2016 416 citations Dima M. Qato, G. Caleb Alexander et al. profile →
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

2016 334 citations G. Caleb Alexander et al. Journal of the American Heart Association profile →
Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US

2020 313 citations G. Caleb Alexander, James Heyward et al. profile →
Evaluation of Aducanumab for Alzheimer Disease

2021 167 citations G. Caleb Alexander et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Caleb Alexander United States	66	5.5k	2.7k	2.4k	2.4k	2.1k	355	16.8k
Muhammad Mamdani Canada	75	4.2k 0.8×	2.3k 0.8×	5.0k 2.1×	3.5k 1.5×	2.1k 1.0×	549	24.0k
David N. Juurlink Canada	62	4.0k 0.7×	892 0.3×	3.3k 1.3×	2.2k 0.9×	2.3k 1.1×	344	17.0k
Wayne A. Ray United States	75	2.7k 0.5×	2.3k 0.8×	4.6k 1.9×	1.8k 0.7×	2.0k 1.0×	215	21.5k
Roger B. Davis United States	86	4.5k 0.8×	1.7k 0.6×	2.7k 1.1×	2.2k 0.9×	1.5k 0.7×	398	29.9k
Albert L. Siu United States	65	2.8k 0.5×	2.6k 1.0×	2.8k 1.1×	2.2k 0.9×	994 0.5×	215	20.8k
Paula A. Rochon Canada	73	2.0k 0.4×	2.3k 0.9×	2.2k 0.9×	1.9k 0.8×	991 0.5×	382	18.0k
Bernard Burnand Switzerland	51	2.2k 0.4×	2.0k 0.7×	3.0k 1.2×	4.7k 2.0×	1.1k 0.5×	302	20.2k
Russell S. Phillips United States	84	5.8k 1.1×	1.6k 0.6×	1.5k 0.6×	1.8k 0.8×	1.6k 0.7×	302	21.0k
Kate L. Lapane United States	60	2.1k 0.4×	1.7k 0.6×	1.2k 0.5×	1.2k 0.5×	902 0.4×	428	12.9k
James S. Goodwin United States	83	2.6k 0.5×	2.1k 0.8×	2.0k 0.8×	2.3k 1.0×	846 0.4×	442	24.7k

Countries citing papers authored by G. Caleb Alexander

Since Specialization

Citations

This map shows the geographic impact of G. Caleb Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Caleb Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Caleb Alexander more than expected).

Fields of papers citing papers by G. Caleb Alexander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Caleb Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Caleb Alexander. The network helps show where G. Caleb Alexander may publish in the future.

Co-authorship network of co-authors of G. Caleb Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of G. Caleb Alexander. A scholar is included among the top collaborators of G. Caleb Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Caleb Alexander. G. Caleb Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Albert W., Allen Zhang, G. Caleb Alexander, et al.. (2025). Interventions to improve patient safety during the COVID-19 pandemic: a systematic review. BMJ Open Quality. 14(2). e003076–e003076.

Lembke, Anna, David Michaels, Cecília Tomori, et al.. (2024). The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectiveness. Health Affairs Scholar. 2(10). qxae119–qxae119. 5 indexed citations

Zheutlin, Alexander R., Nasser Sharareh, Jenny S. Guadamuz, et al.. (2024). Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States. Journal of the American Heart Association. 13(5). e031717–e031717. 1 indexed citations

Klein, Klara R., Anna R. Kahkoska, G. Caleb Alexander, et al.. (2024). Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity. Diabetes Therapy. 15(5). 1169–1186. 1 indexed citations

Wallace, Emma, et al.. (2023). Prescribing cascades in ambulatory care: A structured synthesis of evidence. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(1). 87–96. 7 indexed citations

Moore, Thomas J., et al.. (2022). Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(7). 567–579. 25 indexed citations

Andersen, Kathleen M., Hemalkumar B. Mehta, Michael B. Streiff, et al.. (2022). Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study. Research and Practice in Thrombosis and Haemostasis. 6(5). e12753–e12753. 1 indexed citations

Nopsopon, Tanawin, Ming‐Li Chen, G. Caleb Alexander, et al.. (2022). Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. Journal of Allergy and Clinical Immunology. 151(3). 747–755. 40 indexed citations

Daubresse, Matthew, G. Caleb Alexander, Deidra C. Crews, et al.. (2021). High-dose opioid utilization and mortality among individuals initiating hemodialysis. BMC Nephrology. 22(1). 65–65. 2 indexed citations

10.

Mehta, Hemalkumar B., Kathleen M. Andersen, Omar Mansour, et al.. (2021). Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States. Annals of Internal Medicine. 174(10). 1395–1403. 24 indexed citations

11.

Moore, Thomas J., et al.. (2021). Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study. BMJ Open. 11(8). e048528–e048528. 4 indexed citations

12.

Mehta, Hemalkumar B., Stephan Ehrhardt, Thomas J. Moore, Jodi B Segal, & G. Caleb Alexander. (2020). Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis. BMJ Open. 10(6). e039978–e039978. 33 indexed citations

13.

Baksh, Sheriza, Jodi B Segal, Mara McAdams‐DeMarco, et al.. (2020). Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease. PLoS ONE. 15(10). e0240141–e0240141. 6 indexed citations

14.

Heyward, James, et al.. (2020). Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis. PLoS ONE. 15(6). e0234065–e0234065. 70 indexed citations

15.

Heyward, James, et al.. (2020). Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018. Annals of Internal Medicine. 173(12). 956–963. 3 indexed citations

16.

Baksh, Sheriza, Mara McAdams‐DeMarco, Jodi B Segal, & G. Caleb Alexander. (2018). Cardiovascular safety signals with dipeptidyl peptidase‐4 inhibitors: A disproportionality analysis among high‐risk patients. Pharmacoepidemiology and Drug Safety. 27(6). 660–667. 12 indexed citations

17.

Kaestner, Robert, et al.. (2017). Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence from Medicare Part D. Journal of Risk & Insurance. 86(3). 595–628. 15 indexed citations

18.

Tan, Jingwen, Sunjae Bae, Jodi B Segal, et al.. (2017). Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation. Nephrology. 24(2). 234–244. 22 indexed citations

19.

Brook, Robert H., G. Caleb Alexander, Emmett B. Keeler, et al.. (2010). Health information technology and physicians' knowledge of drug costs.. PubMed. 16(4). e105–10. 7 indexed citations

20.

Alexander, G. Caleb, et al.. (1999). Use of collaborative audit to assist local implementation of the SIGN guideline for prevention of visual impairment in diabetes.. PubMed. 57(1). 29–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact